Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $41.86 million. The enterprise value is -$103.79 million.

Market Cap	41.86M
Enterprise Value	-103.79M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRV has 31.36 million shares outstanding. The number of shares has increased by 69.61% in one year.

Current Share Class	31.36M
Shares Outstanding	31.36M
Shares Change (YoY)	+69.61%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	7.40%
Owned by Institutions (%)	27.64%
Float	16.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.26
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.17, with a Debt / Equity ratio of 0.02.

Current Ratio	11.17
Quick Ratio	11.04
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.41% and return on invested capital (ROIC) is -42.16%.

Return on Equity (ROE)	-62.41%
Return on Assets (ROA)	-39.24%
Return on Invested Capital (ROIC)	-42.16%
Return on Capital Employed (ROCE)	-57.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.07M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.07% in the last 52 weeks. The beta is 1.65, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	-81.07%
50-Day Moving Average	1.23
200-Day Moving Average	4.66
Relative Strength Index (RSI)	55.87
Average Volume (20 Days)	396,721

Short Selling Information

The latest short interest is 1.12 million, so 3.59% of the outstanding shares have been sold short.

Short Interest	1.12M
Short Previous Month	1.05M
Short % of Shares Out	3.59%
Short % of Float	6.74%
Short Ratio (days to cover)	1.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.19M
Pretax Income	-64.12M
Net Income	-83.75M
EBITDA	-92.10M
EBIT	-93.19M
Earnings Per Share (EPS)	-$2.22

Full Income Statement

Balance Sheet

The company has $149.64 million in cash and $3.51 million in debt, giving a net cash position of $146.12 million or $4.66 per share.

Cash & Cash Equivalents	149.64M
Total Debt	3.51M
Net Cash	146.12M
Net Cash Per Share	$4.66
Equity (Book Value)	160.39M
Book Value Per Share	5.12
Working Capital	137.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.12 million and capital expenditures -$2.01 million, giving a free cash flow of -$70.13 million.

Operating Cash Flow	-68.12M
Capital Expenditures	-2.01M
Free Cash Flow	-70.13M
FCF Per Share	-$2.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.61%
Shareholder Yield	-69.61%
Earnings Yield	-197.85%
FCF Yield	-165.68%

Analyst Forecast

The average price target for ACRV is $17.60, which is 1,218.35% higher than the current price. The consensus rating is "Buy".

Price Target	$17.60
Price Target Difference	1,218.35%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-3.63%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1